Onychodystrophy PCR Testing

Targeted Treatment Starts by Identifying the Exact Infectious Organism

  • Causative infectious organisms are colorless and invisible to the eye

  • Laboratory testing provides objective information for precise treatment

  • Determining the exact infectious agents to treat leads to improved patient outcomes and could save patients time & Rx costs

Complete the form below to get answers to your questions about BakoDx’s Onychodystrophy PCR testing with terbinafine resistance.
Please note: individual reflex test options of certain yeast, pseudomonas aeruginosa and terbinafine resistance mutations are pending availability in NY.

Onychodystrophy PCR with terbinafine resistance

  • This field is for validation purposes and should be left unchanged.

Advantages of the BakoDx Onychodystrophy PCR Test
with Terbinafine Resistance

Exact

Exact

Detect genus and species for targeted oral and topical antifungal therapy. Quickly determine if terbinafine treatment is likely to be effective.

Accurate

Accurate

Assess patient results with high confidence.

99.9% analytical specificity 86% clinical sensitivity;¹ Correlates highly with histopathology.

Cost Effective

Cost-effective

Save patients time and Rx costs by knowing before you treat. Focus on testing only for relevant agents of disease.

Required

Required

Document the genus and species information needed for pre-authorization of many antifungal prescriptions.

Covered

Covered

Contracted with all major insurance plans, and over 200 local insurance plans; Covered by Medicare.

Rapid

Rapid

Begin appropriate treatment quickly with 1-2 day turnaround time.

Innovations in PCR Testing
with Terbinafine Resistance

With a proprietary algorithm, BakoDx eliminates extraneous testing and ineffective treatment

BakoDx PCR Reflex Flow

Click image to enlarge

The Difference with Our
Proprietary Technology

  • Reflexes to secondary testing only when positive to reduce medical costs
  • Detects 12 terbinafine resistance mutations in just 4 reactions for cost effectiveness
  • Identifies multiple causative organism targets in a single specimen
  • Detects low levels of concentration of the causative organism
  • Filters out contaminants present in the collected specimen

Click image to enlarge

National Health Plan Requirements

Many antifungal pharmacy programs require positive lab report at the species level and reference PCR availability

BakoDx’s Intelligent Onychodystrophy PCR Testing Report

Actionable reports with information to assist you in making treatment decisions.

  • Diagnosis
  • Treatment Recommendations
  • Relevant Clinical Images
  • Interpretations for All Tests Performed
  • Pathologists Available for Consult
BakoDx Sample Report

Click image to enlarge

Get Started with PCR Testing

Educational Resources for Onychodystrophy

Nail Collection Guide

Optimal Nail Specimen Procedure Guide. Download this easy-to-follow training and reference tool for your staff.

VIEW PDF GUIDE
White Paper

DNA-based detection for onychomycosis correlates better to histopathology than does fungal culture.

READ CLINICAL STUDY
BakoDx Procedure Video

For your reference, we created this Nail Specimen Collection video with assistance from our BakoDx clinical consultants.

WATCH PROCEDURAL VIDEO
BakoDx Paper

Frequency of Terbinafine Drug Resistance in T. rubrum and T. mentagrophytes in U.S. Onychomycotic Samples

READ THE PAPER

¹BakoDx internal validation

Disclaimer: BakoDx, as a partner to your practice, provides learning resources to help you better serve your patients. The information contained within this document should be used at a physician’s discretion. BakoDx assumes no liability for its content..